On a recent Morningstar Investing Insights segment unveiling the 2026 class of exceptional dividend growers, the host offered one caveat worth the entire show: "Valuation was not a component in this s
ZTS eyes a Q1 beat as companion animal products and international growth offset U.S. weakness ahead of its May 7 earnings report.
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zoetis Inc. $ZTS Shares Sold by Caldwell Trust Co

02:45pm, Wednesday, 29'th Apr 2026
Caldwell Trust Co trimmed its position in Zoetis Inc. (NYSE: ZTS) by 64.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm ow

Is ZTS Undervalued? DCF Says Worth $134

07:28am, Wednesday, 29'th Apr 2026
On April 29, 2026, we delve into the DCF analysis for Zoetis Inc (ZTS), a company currently trading at $116.65. The stock has experienced a challenging year, wi
Zoetis (ZTS) reached $116.65 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.

Here's Why Zoetis (ZTS) is a Strong Value Stock

10:43am, Tuesday, 28'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Controversy over a key osteoarthritis pain treatment has sunk Zoetis' stock. Despite the setback, the company has a robust pipeline and solid growth prospects.
Confluence Wealth Services Inc. boosted its position in Zoetis Inc. (NYSE: ZTS) by 553.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

Cwm LLC Reduces Holdings in Zoetis Inc. $ZTS

03:59am, Friday, 24'th Apr 2026
Cwm LLC decreased its position in shares of Zoetis Inc. (NYSE: ZTS) by 61.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fi
Idexx Laboratories, Inc. and Zoetis Inc. are dominant players in animal health, but IDXX outperforms due to superior capital efficiency and recurring revenue flywheel. ZTS trades at a much lower valua
Mirae Asset Global Investments Co. Ltd. raised its position in Zoetis Inc. (NYSE: ZTS) by 10.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities an

Zoetis Inc. $ZTS Shares Sold by Berkeley Inc

03:38am, Friday, 17'th Apr 2026
Berkeley Inc cut its stake in shares of Zoetis Inc. (NYSE: ZTS) by 61.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 20,295 shares of the company's stoc
Zoetis (ZTS) concluded the recent trading session at $119.04, signifying a -1.42% move from its prior day's close.
Zoetis has strong growth prospects and an attractive income program. BioNTech has a rich pipeline that could help jolt the stock as it makes clinical progress.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE